Accelerating Large Population Proteomics in Asia
Accelerating population proteomics
Proteomics excellence: Delivering the most comprehensive, reliable and trusted proteomic platforms for the global biobank community, supporting discovery of new targets and biomarkers to improve human health.
Clinical translation: Supporting the translation of biobank discoveries to advance new drug candidates, accelerate clinical trials, and matching patients with healthcare services and treatments for optimal benefits.
Business partnership: Committed to providing innovative, high quality life science tools to the research community while creating long term collaborative relationships.
Hear from Stephen A. Williams, MD, PhD at the PRECISE-IHCC Conference 2024
21 Aug (Wednesday)
12.55 – 1.20pm SGT, Meeting Room
Stephen A. Williams, MD, PhD
Chief Medical Officer
Standard BioTools
Stephen Williams, MD, PhD, is Chief Medical Officer at Standard BioTools and is responsible for Clinical R&D, Medical Affairs, and Regulatory and Quality. He oversees clinical application of the SomaScan® Platform and has also had roles in launching the life sciences commercial business, assay development and bioinformatics.
Read more about Dr. Williams here.